Prevalence and role of a raised aldosterone to renin ratio in the diagnosis of primary aldosteronism: A debate on the scientific logic of the use of the ratio in practice

Clinical Endocrinology

Volumn 59, Issue 4, 2003, Pages 422-426

  Padfield, Paul L ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOTROPIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MINERALOCORTICOID; RENIN; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ADRENAL CORTEX ADENOMA; ADRENAL HYPERPLASIA; ADRENAL TUMOR; ADRENALECTOMY; ALDOSTERONE RELEASE; BLOOD PRESSURE REGULATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; ESSENTIAL HYPERTENSION; HORMONE RESPONSE; HUMAN; HYPERTENSION; HYPOKALEMIA; METABOLIC ALKALOSIS; NOTE; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; PREVALENCE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL;

ADRENAL GLANDS; ALDOSTERONE; ANGIOTENSIN II; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TESTS, ROUTINE; HUMANS; HYPERALDOSTERONISM; HYPERPLASIA; HYPERTENSION; RENIN;

EID: 0141728384     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01817.x     Document Type: Note

References (26)

1. Baer, L., Brunner, H.R., Buhler, F. & Laragh, J.A. (1972) Pseudo-primary aldosteronism, a variant of low-renin essential hypertension?. In: Hypertension '72 (eds J. Henest & E. Loiw), pp. 459-472. Springer Verlag, Berlin.
2. Brown, J.J., Davies, D.L., Ferriss, J.B., Fraser, R., Haywood, E., Lever, A.F. & Robertson, J.I. (1972) Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin. British Medical Journal, 2, 729-734.
3. Carey, R.M., Douglas, J.G., Schweikert, J.R. & Liddle, G.W. (1972) The syndrome of essential hypertension and suppressed plasma renin activity. Normalization of blood pressure with spironolactone. Archives of Internal Medicine, 130, 849-854.
4. Conn, J.W. (1955) Primary aldosteronism, a new clinical syndrome. Journal of Laboratory and Clinical Medicine, 45, 3-17.
5. Davies, D.L., Beevers, D.G., Brown, J.J., Fraser, R., Lever, A.F., Mason, P.A., Morton, J.J., Padfield, P.L., Robertson, J.I.S., Titterington, M. & Tree, M. (1979) Aldosterone and its stimuli in normal and hypertensive man: are essential hypertension and primary hyperaldosteronism without tumour the same condition? Journal of Endocrinology, 81, 79p-91p.
6. Dickerson, J.E., Hingorani, A.D., Ashby, M.J., Palmer, C.R. & Brown, M.J. (1999) Optimisation of antihypertensive treatment by cross-over rotation of four major classes. Lancet, 353, 2008-2013.
7. Espiner, E.A. & Donald, R.A. (1980) Aldosterone regulation in primary aldosteronism: influence of salt balance, posture and ACTH. Clinical Endocrinology, 12, 277-286.
8. Ferriss, J.B., Beevers, D.G., Brown, J.J., Fraser, R., Lever, A.F., Padfield, P.L. & Robertson, J.I.S. (1978) Low-renin ('primary') hyperaldosteronism differential diagnosis and distinction of subgroups within the syndrome. American Heart Journal, 95, 641-658.
9. Ganguly, A. & Luetscher, J.A. (1976) Spironolactone therapy in primary aldosteronism: diagnostic and therapeutic implications. In: Systemic Effects of Antihypertensive Agents (ed. M.P. Sambhi), pp. 383-392. Stratton Intercontinental Medical Books, New York.
10. Gordon, R.D., Stowasser, M., Klemm, S.A. & Tunny, T.J. (1994) Primary aldosteronism and other forms of mineralocorticoid hypertension. In: Textbook of Hypertension (ed. J. Swales), pp. 865-892. Blackwell Scientific, Oxford.
11. Harding, M.B., Smith, R.L., Himmelstein, S.I., Harrison, K., Phillips, H.R., Scwab, S.J., Hermiller, J.B., Davidson, C.J. & Bashore, T.M. (1992) Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. Journal of the American Society of Nephrology, 2, 1608-1616.
12. Hiramatsu, K., Yamada, T., Jukimura, Y., Komiya, I., Ichikawa, K., Ishihara, M., Nagata, H. & Izumiyama, T. (1981) A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Archives of Internal Medicine, 141, 1589-1594.
13. van Jaarsveld, B.C., Krijnen, P., Pieterman, H., Derkx, F.H., Deinum, J., Postma, C.T., Dees, A., Woittiez, A.J., Bartelink, A.K., Man in 'T Veld A.J. & Schalekamp M.A.' (2000) The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine, 342, 1007-1014.
14. Kaplan, N.M. (2001) Cautions over the current epidemic of primary aldosteronism. Lancet, 357, 953-954.
15. Kisch, E.S., Dluhy, R.G. & Williams, G.H. (1976) Enhanced aldosterone response to angiotensin II in human hypertension. Circulation Research, 38, 502-505.
16. Lim, P.O., Jung, R.T. & MacDonald, T.M. (1999) Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study. British Journal of Clinical Pharmacology, 48, 756-760.
17. Montori, V.M., Schwartz, G.L., Chapman, A.B., Boerwinlde, E. & Turner, S.T. (2001) Validity of the aldosterone renin ratio used to screen for primary aldosteronism. Mayo Clinic Proceedings, 76, 877-882.
18. Montori, V.M. & Young, W.F. (2002) Use of plasma aldosterone concentration to plasma renin ratio as a screening test for primary aldosteronism: a systematic review of the literature. Endocrinology and Metabolism Clinics of North America, 31, 619-632.
19. Padfield, P.L. (2002) Primary aldosteronism, a common entity? The myth persists. Journal of Human Hypertension, 16, 159-162.
20. Padfield, P.L., Beevers, D.G., Brown, J.J., Davies, D.L., Lever, A.F., Robertson, J.I.S. & Tree, M. (1975) Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity? Lancet, 1, 548-550.
21. Padfield, P.L., Brown, J.J., Davies, D.L., Fraser, R., Lever, A.F., Morton, J.J. & Robertson, J.I.S. (1981) The myth of idiopathic hyperaldosteronism. Lancet, 2, 83-84.
22. Radin, D.R., Manoogian, C. & Nadicr, J.L. (1992) Diagnosis of primary hyperaldosteronism: importance of correlating CT findings with endocrinologic studies. American Journal of Roentgenology, 158, 553-557.
23. Spark, R.F. & Melby, J.C. (1968) Aldosteronism in hypertension: the spironolactone response test. Annals of Internal Medicine, 169, 685-695.
24. Stowasser, M. (2001) Primary aldosteronism: revival of a syndrome. Journal of Hypertension, 3, 363-366.
25. Wisgerhof, M., Carpenter, P.C. & Brown, R.D. (1978) Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism. Journal of Clinical Endocrinology and Metabolism, 47, 938-943.
26. Young, W.F., Hogan, M.J., Klee, G.G., Grant, C.S. & van Heerden, J.A. (1990) Primary aldosteronism: diagnosis and treatment. Mayo Clinic Proceedings, 65, 96-110.